Concord, NEW%20SOUTH%20WALES2 Active Studies

Interstitial Cystitis Clinical Trials in Concord, NEW%20SOUTH%20WALES

Find 2 actively recruiting interstitial cystitis clinical trials in Concord, NEW%20SOUTH%20WALES. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
1,261
Enrolling

Recruiting Interstitial Cystitis Studies in Concord

About Interstitial Cystitis Clinical Trials in Concord

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 2 interstitial cystitis clinical trials recruiting participants in Concord, NEW%20SOUTH%20WALES. These studies are seeking a combined 1,261 participants. Research is being sponsored by Sanofi, Mesoblast, Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Concord — FAQ

Are there interstitial cystitis clinical trials in Concord?

Yes, there are 2 interstitial cystitis clinical trials currently recruiting in Concord, NEW%20SOUTH%20WALES. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Concord?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Concord research site will contact you about next steps.

Are clinical trials in Concord free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Concord studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 2 active trials in Concord are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated March 2, 2026 from ClinicalTrials.gov